Bio-Rad Laboratories Interest Expense 2011-2026 | BIO

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Bio-Rad Laboratories

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
48.9 M	49.4 M	38.1 M	1.55 M	21.9 M	23.4 M	24 M	23 M	23.4 M	21.7 M	22.1 M	61.3 M	51.1 M	53.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
61.3 M	1.55 M	33.1 M

Quarterly Interest Expense Bio-Rad Laboratories

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
12.6 M	12 M	12.2 M	12.3 M	12.3 M	12.4 M	12.3 M	12.3 M	-	11.7 M	10.7 M	4.05 M	-	426 K	363 K	398 K	-	5.73 M	5.74 M	5.69 M	-	5.52 M	5.84 M	5.99 M	-	6.06 M	5.98 M	5.78 M	-	5.87 M	6.04 M	5.32 M	-	5.63 M	5.63 M	5.58 M	-	5.82 M	4.83 M	5 M	-	7.71 M	5.56 M	3.86 M	-	31.6 M	11.7 M	11 M	-	11.9 M	12.4 M	13.2 M	-	12.3 M	12 M	16.8 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
31.6 M	363 K	8.59 M

Interest Expense of other stocks in the Medical devices industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Abiomed ABMD	58.7 M	-	-	$ 17.2 B	USA
Allied Healthcare Products AHPI	191 K	-	3.58 %	$ 2.21 M	USA
Alphatec Holdings ATEC	24.9 M	$ 20.75	-1.38 %	$ 2.97 B	USA
Acutus Medical AFIB	5.66 M	-	-26.83 %	$ 2.62 M	USA
Apyx Medical Corporation APYX	2.48 M	$ 3.55	1.51 %	$ 123 M	USA
Cognyte Software Ltd. CGNT	-1.61 M	$ 9.08	-3.4 %	$ 652 M	Israel
Boston Scientific Corporation BSX	305 M	$ 94.69	-0.71 %	$ 139 B	USA
Apollo Endosurgery APEN	4.67 M	-	-	$ 475 M	USA
Conformis CFMS	2.02 M	-	-	$ 16.4 M	USA
Cardiovascular Systems CSII	1.63 M	-	0.15 %	$ 844 M	USA
Cutera CUTR	-244 K	-	-10.19 %	$ 1.99 M	USA
BioSig Technologies BSGM	23 K	-	37.08 %	$ 85.7 M	USA
Bruker Corporation BRKR	-38.2 M	$ 48.19	2.28 %	$ 7.18 K	USA
Electromed ELMD	78 K	$ 28.0	-3.85 %	$ 237 M	USA
Eargo EAR	549 K	-	-	$ 10.2 M	USA
Abbott Laboratories ABT	376 M	$ 124.11	-0.94 %	$ 216 B	USA
EDAP TMS S.A. EDAP	232 K	$ 3.34	1.37 %	$ 125 M	France
Second Sight Medical Products EYES	1.19 M	-	-0.97 %	$ 54.4 M	USA
Neovasc NVCN	133 K	-	-	$ 111 M	Canada
IRadimed Corporation IRMD	164 K	$ 97.29	0.01 %	$ 1.23 B	USA
Dynatronics Corporation DYNT	410 K	-	14.99 %	$ 929 K	USA
LivaNova PLC LIVN	1.01 M	$ 61.59	0.1 %	$ 3.34 B	Britain
LENSAR LNSR	660 K	$ 11.58	-0.43 %	$ 133 M	USA
Align Technology ALGN	7.68 M	$ 156.27	0.08 %	$ 11.7 B	USA
Accuray Incorporated ARAY	13 M	$ 0.85	3.12 %	$ 87.4 M	USA
Avinger AVGR	1.72 M	-	-20.74 %	$ 369 K	USA
ClearPoint Neuro CLPT	-40 K	$ 13.99	2.27 %	$ 378 M	USA
FONAR Corporation FONR	347 K	$ 18.55	-0.08 %	$ 122 M	USA
AxoGen AXGN	-199 K	$ 31.21	-4.64 %	$ 1.38 B	USA
Axonics Modulation Technologies AXNX	-2.43 M	-	-	$ 3.31 B	USA
CONMED Corporation CNMD	37.3 M	$ 40.78	0.49 %	$ 1.26 B	USA
OrthoPediatrics Corp. KIDS	-1.07 M	$ 17.4	-2.03 %	$ 402 M	USA
Globus Medical GMED	2.2 M	$ 86.15	-1.33 %	$ 11.7 B	USA
Integra LifeSciences Holdings Corporation IART	3.94 M	$ 12.35	-0.56 %	$ 951 M	USA
Aziyo Biologics AZYO	5.8 M	-	1.37 %	$ 20.5 M	USA
Myomo MYO	21.1 K	$ 0.97	6.92 %	$ 6.84 M	USA